EPO Experimentelle Pharmakologie und Onkologie Berlin-Buch GmbH
About us
EPO GmbH is a Berlin-based preclinical contract research organization (CRO) that specializes in oncology and immuno-oncology. Since its founding in 1997, EPO has combined over 25 years of scientific expertise with a strong commitment to translational cancer research.
EPO serves clients worldwide and offers customized, high-quality preclinical services. Its portfolio includes over 1,000 well-characterized patient-derived xenograft (PDX) models, as well as syngeneic and cell line-derived xenograft models. EPO is also recognized for its extensive experience with humanized models, which it has used in studies for over a decade.
EPO is located at the Research Campus Berlin-Buch and operates over 1,300 m² of laboratory space. It employs around 50 professionals, including a highly qualified scientific team.
Address
Robert-Rössle-Str. 10
13125 Berlin
Germany
E-mail: sylvia.niebruegge@epo-berlin.com
Phone: +49-151-24120034
Internet: epo-berlin.com